Ophthalmology

A topic in the Science corpus, drawn from 818 papers.

Trusted voices in Ophthalmology

Ordered by the trust Ophthalmology's own network concentrates on each researcher, most first.

  1. Anurag Ranjan — trusted by 66 researchers here
  2. Michael J. Black — trusted by 66 researchers here
  3. Michael David Abràmoff — trusted by 39 researchers here
  4. Richard A. Armstrong — trusted by 28 researchers here
  5. Renzo Perfetti — trusted by 31 researchers here
  6. Elisa Ricci — trusted by 31 researchers here
  7. Michael H. Goldbaum — trusted by 30 researchers here
  8. Olga Veksler — trusted by 15 researchers here
  9. Ana Maria Mendonça — trusted by 28 researchers here
  10. Aurélio J. C. Campilho — trusted by 28 researchers here
  11. B. van Ginneken — trusted by 30 researchers here
  12. Joes Staal — trusted by 30 researchers here

Most-cited papers in Ophthalmology

Ordered by the recorded citation count from the source corpus; a citation is not an endorsement.

  1. The biology of VEGF and its receptors (2003, Nature Medicine) — 9,751 citations
  2. The number of people with glaucoma worldwide in 2010 and 2020 (2006, British Journal of Ophthalmology) — 7,386 citations
  3. Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. (2016) — 6,915 citations
  4. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. (2014, Ophthalmology (Rochester, Minn.)) — 6,813 citations
  5. [Diabetic retinopathy]. (2001, Nihon rinsho. Japanese journal of clinical medicine) — 6,191 citations
  6. [Age-related macular degeneration]. (2006, La Revue de l Infirmière) — 5,595 citations
  7. Complement Factor H Polymorphism in Age-Related Macular Degeneration (2005, Science) — 4,849 citations
  8. Global Prevalence and Major Risk Factors of Diabetic Retinopathy (2012) — 4,761 citations
  9. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. (2014, Lancet Global Health) — 4,554 citations
  10. Ridge-based vessel segmentation in color images of the retina (2004, IEEE Transactions on Medical Imaging) — 4,272 citations
  11. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. (2005, American journal of ophthalmology-glaucoma) — 4,150 citations
  12. The Pathophysiology and Treatment of Glaucoma (2014, Journal of the American Medical Association (JAMA)) — 3,738 citations
  13. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. (2003, Ophthalmology (Rochester, Minn.)) — 3,533 citations
  14. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. (2002, A M A Archives of Ophthalmology) — 3,500 citations
  15. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis (2020, The Lancet) — 3,461 citations
  16. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. (2006, New England Journal of Medicine) — 3,445 citations
  17. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy (2020, Journal of Thrombosis and Haemostasis) — 3,406 citations
  18. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. (2002, New England Journal of Medicine) — 3,179 citations
  19. Femtosecond laser micromachining in transparent materials (2008) — 3,035 citations
  20. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. (2001, A M A Archives of Ophthalmology) — 2,967 citations
  21. Prevalence of age-related macular degeneration in the United States. (2004, A M A Archives of Ophthalmology) — 2,935 citations
  22. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. (2005, Clinical Infectious Diseases) — 2,922 citations
  23. When to use the Bonferroni correction (2014, Ophthalmic & physiological optics) — 2,913 citations
  24. Ranibizumab in neovascular age-related macular degeneration (2006, Clinical Interventions in Aging) — 2,830 citations
  25. Ranibizumab for neovascular age-related macular degeneration. (2006, New England Journal of Medicine) — 2,821 citations
  26. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. (2002, A M A Archives of Ophthalmology) — 2,771 citations
  27. The retinal pigment epithelium in visual function. (2005, Physiological Reviews) — 2,753 citations
  28. Locating blood vessels in retinal images by piecewise threshold probing of a matched filter response (2000, IEEE Transactions on Medical Imaging) — 2,694 citations
  29. Revised diagnostic criteria for neuromyelitis optica (2006, Neurology) — 2,656 citations
  30. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration (2011, New England Journal of Medicine) — 2,654 citations
  31. The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration (2000) — 2,549 citations
  32. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration (2005, Science) — 2,535 citations
  33. Improved overall survival in melanoma with combined dabrafenib and trametinib. (2015, New England Journal of Medicine) — 2,453 citations
  34. Clinically applicable deep learning for diagnosis and referral in retinal disease (2018) — 2,402 citations
  35. The definition and classification of glaucoma in prevalence surveys (2002, British Journal of Ophthalmology) — 2,396 citations
  36. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. (2012, Ophthalmology (Rochester, Minn.)) — 2,368 citations
  37. Microvascular and Macrovascular Complications of Diabetes (2008, Clinical Diabetes) — 2,352 citations
  38. Development of the 25-item National Eye Institute Visual Function Questionnaire. (2001, A M A Archives of Ophthalmology) — 2,305 citations
  39. 2016 ACR-EULAR Classification Criteria for primary Sjögren’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts (2016, Arthritis & Rheumatology) — 2,294 citations
  40. Pegaptanib for neovascular age-related macular degeneration. (2004, New England Journal of Medicine) — 2,264 citations
  41. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study (2000, British medical journal) — 2,240 citations
  42. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. (2003, A M A Archives of Ophthalmology) — 2,146 citations
  43. Safety and efficacy of gene transfer for Leber's congenital amaurosis. (2008, New England Journal of Medicine) — 2,123 citations
  44. Pharmacological and rAAV Gene Therapy Rescue of Visual Functions in a Blind Mouse Model of Leber Congenital Amaurosis (2005, PLoS Medicine) — 2,113 citations
  45. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. (2005, Proceedings of the National Academy of Sciences of the United States of America) — 2,084 citations
  46. Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes (2017) — 2,075 citations
  47. The role of oxidative stress in the pathogenesis of age-related macular degeneration. (2000, Survey of ophthalmology) — 2,041 citations
  48. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. (2021, Ophthalmology (Rochester, Minn.)) — 2,034 citations
  49. Improved survival with MEK inhibition in BRAF-mutated melanoma. (2012, New England Journal of Medicine) — 1,998 citations
  50. Photodynamic therapy: a new antimicrobial approach to infectious disease? (2004, Photochemical and Photobiological Sciences) — 1,941 citations

Most active researchers

By papers in this topic: a volume measure, not trust.